phosphodiesterase 5 inhibitors

Preferred Label : phosphodiesterase 5 inhibitors;

MeSH definition : Compounds that specifically inhibit PHOSPHODIESTERASE 5.;

MeSH synonym : inhibitors, phosphodiesterase 5; PDE5 inhibitors; inhibitors, PDE5; PDE-5 inhibitors; inhibitors, PDE-5; PDE 5 inhibitors; phosphodiesterase type 5 inhibitors; PDE5 Inhibitor; Inhibitor, PDE5; Phosphodiesterase 5 Inhibitor; 5 Inhibitor, Phosphodiesterase; Inhibitor, Phosphodiesterase 5; PDE-5 Inhibitor; Inhibitor, PDE-5; PDE 5 Inhibitor; Phosphodiesterase Type 5 Inhibitor;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058986;

UMLS CUI

C1318700;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Substance with phosphodiesterase 5 inhibitor mechanism of action (substance) [SNOMED CT concept]
MeSH Descriptor(s) used for indexing
- cyclic nucleotide phosphodiesterases, type 5 [MeSH Descriptor]
Record concept(s)
- phosphodiesterase 5 inhibitors [MeSH concept]
See also inter- (CISMeF)
- Phosphodiesterase 5 inhibitor (disposition) [SNOMED CT concept]
- Product containing phosphodiesterase 5 inhibitor (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one [MeSH Supplementary Concept]
- N-(6-aminohexyl)-3-(1-ethyl-3-methyl-7-oxo-6,7-dihydro-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-propoxybenzenesulfonamide [MeSH Supplementary Concept]
- Sildenafil Citrate [MeSH Descriptor]
- T 1032 [MeSH Supplementary Concept]
- Tadalafil [MeSH Descriptor]
- Vardenafil Dihydrochloride [MeSH Descriptor]
- aildenafil [MeSH Supplementary Concept]
- methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate [MeSH Supplementary Concept]
- mirodenafil [MeSH Supplementary Concept]
- udenafil [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing phosphodiesterase 5 inhibitor (product) [SNOMED CT concept]
- Substance with phosphodiesterase 5 inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients